Changes in Study Status and Arms and Interventions With Illuminate-301 ... | IDRA Message Board Posts

Idera Pharmaceuticals, Inc

  IDRA website

IDRA   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1445 of 1524  at  6/17/2019 4:28:23 PM  by

auh2oman


Changes in Study Status and Arms and Interventions With Illuminate-301 ...

Arms Assigned Interventions
Experimental: Arm A: ipilimumab
ipilimumab 3 mg/kg intravenous
Drug: Ipilimumab
4 doses administered intravenously at a dose of 3 mg/kg over 90 minutes on Weeks 1 2, 4 5, 7 8, and 10. 11.

Other Names:
  • Yervoy®
Experimental: Arm B: IMO-2125 plus ipilimumab
IMO-2125 by intratumoral injection plus ipilimumab 3 mg/kg intravenous
Drug: Ipilimumab
4 doses administered intravenously at a dose of 3 mg/kg over 90 minutes on Weeks 1 2, 4 5, 7 8, and 10. 11.

Other Names:
  • Yervoy®
Drug: IMO-2125
IMO-2125 intratumoral injection administered as 9 doses on Weeks 1, 2, 3, 5, 8, 11, 16, 20, and 24.
 
 
 
 https://clinicaltrials.gov/ct2/history/NCT03445533?A=72&B=73&C=merged#StudyPageTop


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 121
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
1446 Re: Changes in Study Status and Arms and Interventions With Illuminate-301 ... cert77 1 6/17/2019 5:46:40 PM
1447 Re: Changes in Study Status and Arms and Interventions With Illuminate-301 ... raferjack 3 6/18/2019 8:46:31 AM


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...